Attar, E. C., Amrein, P. C., Fraser, J. W., Fathi, A., McAfee, S., Wadleigh, M., . . . Ballen, K. K. (2013). Phase I Dose Escalation Study of Bortezomib in Combination with Lenalidomide in Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).
Citação norma ChicagoAttar, Eyal C., et al. Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). 2013.
Citação norma MLAAttar, Eyal C., et al. Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.